Abstract
Central circuits known to regulate food intake and energy expenditure also affect central cardiovascular regulation. For example, both the melanocortin and neuropeptide Y (NPY) peptide families, known to regulate food intake, also produce central hypertensive effects. Members of both families share a similar C-terminal amino acid residue sequence, RF(Y) amide, a sequence distinct from that required for melanocortin receptor binding. A recently delineated family of RFamide receptors recognizes both of these C-terminal motifs. We now present evidence that an antagonist with Y1 and RFamide receptor activity, BIBO3304, will attenuate the central cardiovascular effects of both gamma-melanocyte stimulating hormone (γ-MSH) and NPY. The use of synthetic melanocortin and NPY peptide analogs excluded an interaction with melanocortin or Y family receptors. We suggest that the anatomical convergence of NPY and melanocortin neurons on cardiovascular control centers may have pathophysiological implications through a common or similar RFamide receptor(s), much as they converge on other nuclei to coordinately control energy homeostasis.
Original language | English (US) |
---|---|
Pages (from-to) | 312-324 |
Number of pages | 13 |
Journal | Endocrine |
Volume | 35 |
Issue number | 3 |
DOIs | |
State | Published - Jun 2009 |
Externally published | Yes |
Keywords
- Central nervous system
- Central vasopressin system
- Hypertensive effects
- Neuropeptide Y
- RFamide peptides
- RFamide receptors
- Y1 antagonists
- γ-MSH
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Endocrinology